An odd press release from Major League Baseball just now:
“The Office of the Commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis. The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program.”
This coming on the heels of reports earlier this week that Tejada was mentioned in the Biogenesis documents and faced discipline thereunder unless he accepted a suspension for stimulant use.
Either those reports were wrong or else Major League Baseball doesn’t want to look like it engaged in drug suspension horse-trading.
The Braves released veteran infielder/outfielder Jose Bautista on Sunday, per a team announcement. Right-hander Lucas Sims was recalled from Triple-A Gwinnett in a corresponding move.
Bautista, 37, was recruited by the Braves in mid-April as a potential third base option. He inked a minor league deal with the club and lasted just 12 games in the majors, during which he batted a meager .143/.250/.343 with three extra-base hits and a .593 OPS across 40 plate appearances. While he isn’t too far removed from his last productive season in the big leagues — he collected 40 home runs, a .250 average and 5.3 fWAR with the Blue Jays in 2015 — his power has been noticeably declining over the last three years, and it’s clear the Braves don’t have enough time or opportunity to wait for him to get his groove back.
Without Bautista, Johan Camargo is expected to handle the hot corner on a daily basis. The 24-year-old infielder is working through his sophomore season at the major league level and entered Sunday’s game batting .226/.368/.403 with six extra bases and a .772 OPS in 76 PA. General manager Alex Anthopoulos acknowledged that top infield prospect Austin Riley could also get a shot at playing third base sometime in 2018, though the club has no current plans to promote him from Triple-A at the moment.